Effect of a hydrogen (H2)-enriched solution on the albumin redox of hemodialysis patients

Hemodialysis International

Volumn 18, Issue 2, 2014, Pages 459-466

  Terawaki, Hiroyuki ^a   Zhu, Wan Jun ^b   Matsuyama, Yukie ^c   Terada, Tomoyoshi ^c   Takahashi, Yasuhito ^a   Sakurai, Kaoru ^a   Kabayama, Shigeru ^b   Miyazaki, Mariko ^b   Itami, Noritomo ^d   Nakazawa, Ryoichi ^e   Ito, Sadayoshi ^b   Era, Seiichi ^c   Nakayama, Masaaki ^a,b  

^a FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

^b TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c GIFU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d Nikko Memorial Hospital   (Japan)

^e Department of Urology   (Japan)

Author keywords

Albumin redox state; Hemodialysis; Molecular hydrogen; Oxidative stress

Indexed keywords

ALBUMIN; GLUTATHIONE; HYDROGEN; HYDROGEN PEROXIDE; DIALYSIS FLUID; SERUM ALBUMIN;

ADULT; ALBUMIN BLOOD LEVEL; ARTICLE; ARTIFICIAL KIDNEY; BLOOD CARBON DIOXIDE TENSION; BLOOD OXYGEN TENSION; BLOOD SAMPLING; CHRONIC GLOMERULONEPHRITIS; CLINICAL ARTICLE; DIABETIC NEPHROPATHY; DIALYSATE; FEMALE; HEMODIALYSIS PATIENT; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; KIDNEY DISEASE; MALE; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PH; BLOOD; CARDIOVASCULAR DISEASE; CHEMISTRY; CONTROLLED STUDY; CROSSOVER PROCEDURE; KIDNEY FAILURE, CHRONIC; METABOLISM; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY; PROCEDURES; RANDOMIZED CONTROLLED TRIAL; RENAL REPLACEMENT THERAPY;

CARDIOVASCULAR DISEASES; CROSS-OVER STUDIES; DIALYSIS SOLUTIONS; FEMALE; GLUTATHIONE; HUMANS; HYDROGEN; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; OXIDATION-REDUCTION; OXIDATIVE STRESS; RENAL DIALYSIS; SERUM ALBUMIN;

EID: 84898596329     PISSN: 14927535     EISSN: 15424758     Source Type: Journal    
DOI: 10.1111/hdi.12112     Document Type: Article

References (26)

1. Himmelfarb J, Stenvinkel P, Ikizler TA, Hakim RM. The elephant in uremia: Oxidant stress as a unifying concept of cardiovascular disease in uremia. Kidney Int. 2002; 62:1524-1538.
2. Terawaki H, Era S, Nakayama M, Hosoya T. Decrease in reduced-form albumin among chronic kidney disease patients: New insights in cardiovascular complications. Ther Apher Dial. 2011; 15:156-160.
3. Terawaki H, Takada Y, Era S, etal. The redox state of albumin and serious cardiovascular incidence in hemodialysis patients. Ther Apher Dial. 2010; 14:465-471.
4. Terawaki H, Matsuyama Y, Matsuo N, etal. A lower level of reduced albumin induces serious cardiovascular incidence among peritoneal dialysis patients. Clin Exp Nephrol. 2012; 16:629-635.
5. Terawaki H, Nakayama K, Matsuyama Y, etal. Dialyzable uremic solutes contribute to enhanced oxidation of serum albumin in regular hemodialysis patients. Blood Purif. 2007; 25:274-279.
6. Niwa T. Indoxyl sulfate is a nephro-vascular toxin. J Ren Nutr. 2010; 20(Suppl 5):S2-S6.
7. Gawlowski T, Stratmann B, Stirban AO, Negrean M, Tschoepe D. AGEs and methylglyoxal induce apoptosis and expression of Mac-1 on neutrophils resulting in platelet-neutrophil aggregation. Thromb Res. 2007; 121:117-126.
8. Witko-Sarsat V, Gausson V, Nguyen AT, etal. AOPP-induced activation of human neutrophil and monocyte oxidative metabolism: A potential target for N-acetylcysteine treatment in dialysis patients. Kidney Int. 2003; 64:82-91.
9. Nakayama K, Nakayama M, Iwabuchi M, etal. Plasma alpha-oxoaldehyde levels in diabetic and nondiabetic chronic kidney disease patients. Am J Nephrol. 2008; 28:871-878.
10. Nakayama M, Nakayama K, Zhu WJ, etal. Polymorphonuclear leukocyte injury by methylglyoxal and hydrogen peroxide: A possible pathological role for enhanced oxidative stress in chronic kidney disease. Nephrol Dial Transplant. 2008; 23:3096-3102.
11. Toyohara T, Suzuki T, Morimoto R, etal. SLCO4C1 transporter eliminates uremic toxins and attenuates hypertension and renal inflammation. J Am Soc Nephrol. 2009; 20:2546-2555.
12. Sela S, Shurtz-Swirski R, Cohen-Mazor M, etal. Primed peripheral polymorphonuclear leukocyte: A culprit underlying chronic low-grade inflammation and systemic oxidative stress in chronic kidney disease. J Am Soc Nephrol. 2005; 16:2431-2438.
13. Ward RA, McLeish KR. Polymorphonuclear leukocyte oxidative burst is enhanced in patients with chronic renal insufficiency. J Am Soc Nephrol. 1995; 5:1697-1702.
14. Yoon JW, Pahl MV, Vaziri ND. Spontaneous leukocyte activation and oxygen-free radical generation in end-stage renal disease. Kidney Int. 2007; 71:167-172.
15. Nakayama K, Terawaki H, Nakayama M, Iwabuchi M, Sato T, Ito S. Reduction of serum antioxidative capacity during hemodialysis. Clin Exp Nephrol. 2007; 11:218-224.
16. Ohsawa I, Ishikawa M, Takahashi K, etal. Hydrogen acts as a therapeutic antioxidant by selectively reducing cytotoxic oxygen radicals. Nat Med. 2007; 13:688-694.
17. Ohta S. Recent progress toward hydrogen medicine: Potential of molecular hydrogen for preventive and therapeutic applications. Curr Pharm Des. 2011; 17:2241-2252.
18. Nakayama M, Kabayama S, Terawaki H, etal. Less-oxidative hemodialysis solution rendered by cathode-side application of electrolyzed water. Hemodial Int. 2007; 11:322-327.
19. Nakayama M, Kabayama S, Nakano H, etal. Biological effects of electrolyzed water in hemodialysis. Nephron Clin Pract. 2009; 112:c9-15.
20. 2) produced by water electrolysis: A clinical trial. Nephrol Dial Transplant. 2010; 25:3026-3033.
21. Jin C, Hu C, Polichnowski A, etal. Effects of renal perfusion pressure on renal medullary hydrogen peroxide and nitric oxide production. Hypertension. 2009; 53:1048-1053.
22. 2 leads to hypertension. Hypertension. 2003; 42:25-30.
23. Ogasawara Y, Namai T, Togawa T, Ishii K. Formation of albumin dimers induced by exposure to peroxides in human plasma: A possible biomarker for oxidative stress. Biochem Biophys Res Commun. 2006; 340:353-358.
24. Moriarty-Craige SE, Jones DP. Extracellular thiols and thiol/disulfide redox in metabolism. Annu Rev Nutr. 2004; 24:481-509.
25. Shirahata S, Kabayama S, Nakano M, etal. Electrolyzed-reduced water scavenges active oxygen species and protects DNA from oxidative damage. Biochem Biophys Res Commun. 1997; 234:269-274.
26. Huang KC, Yang CC, Lee KT, Chien CT. Reduced hemodialysis-induced oxidative stress in end-stage renal disease patients by electrolyzed reduced water. Kidney Int. 2003; 64:704-714.